Needham & Company Downgrades GenMark Diagnostics (GNMK) to Hold, Following Acquisition Mar 15, 2021 11:09AM
GenMark Diagnostics to Participate in Upcoming Investor Conferences Dec 28, 2020 04:05PM
GenMark Diagnostics to Participate in Upcoming Investor Conferences Dec 28, 2020 04:05PM
GenMark Diagnostics to Participate in Upcoming Investor Conferences Jul 29, 2020 04:05PM
GenMark Diagnostics to Participate in Upcoming Investor Conferences Jul 29, 2020 04:05PM


Jul 8, 2020 07:19AM GenMark Diagnostics (GNMK) PT Raised to $19 at Needham & Company After Positive Preannouncement
May 11, 2020 04:01PM GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 11, 2020 04:01PM GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 7, 2020 05:47AM GenMark Diagnostics (GNMK) Prices 7.254M Share Common Offering at $9.65/Sh
May 6, 2020 10:59PM GenMark Prices Public Offering of Common Stock
May 6, 2020 10:59PM GenMark Prices Public Offering of Common Stock
Feb 22, 2019 08:50AM GenMark Diagnostics (GNMK) PT Rises To $12 Despite Growing Pains
Sep 13, 2017 07:33AM GenMark Diagnostics (GNMK) PT Lowered to $15 at Needham & Company Following ePlex Launch
Jun 13, 2017 07:39AM GenMark Diagnostics (GNMK) PT Raised to $17 at Needham & Company; 'Announces 510(k) Clearance for ePlex & Respiratory Panel'
Jun 12, 2017 10:48AM GenMark Diagnostics (GNMK) PT Raised to $17 at Needham & Company; Reiterates Buy
May 3, 2017 06:42AM GenMark Diagnostics (GNMK): In Line With Preannouncement, Raising PT - Needham
Apr 21, 2017 08:23AM Needham & Company Reiterates Buy Rating and $15 PT on GenMark Diagnostics (GNMK) Following In-Line Pre-Announcement
Mar 28, 2017 06:53PM GenMark Diagnostics to Present at 16th Annual Needham Healthcare Conference
Mar 1, 2017 07:34AM Needham & Company Reiterates Buy on GenMark Diagnostics (GNMK) Following 4Q
Jan 24, 2017 07:00AM GenMark Diagnostics (GNMK) PT Raised to $15 at Needham & Company
Jun 24, 2016 09:11AM ResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham & Company
Jun 16, 2016 06:51AM Needham & Company Raises Price Target as GenMark Diagnostics (GNMK) Prepares for Euro Launch
Feb 24, 2016 10:36AM Needham & Company Reiterates a Buy Rating as GenMark Diagnostics (GNMK) Reports 4Q Results Consistent with Preannouncement
Oct 28, 2015 07:11AM GenMark Diagnostics (GNMK) Pushes ePlex Launch to 2016; Needham & Company Cuts Price Target to $13
Apr 6, 2015 07:13AM GenMark Diagnostics (GNMK) European ePlex Launch First of Many Catalysts, Needham & Company Says
Feb 25, 2015 07:29AM GenMark Diagnostics (GNMK) PT Raised to $16 at Needham & Company
Jun 16, 2014 07:30AM Needham & Company Comments on Sector Implications Amid Medtronic (MDT)/Covidien (COV) Megadeal
May 7, 2014 09:03AM GenMark (GNMK) Bullish Stance Reiterated at Needham & Company on Solid Q1
Dec 19, 2013 09:30AM Pre-Open Stock Movers 12/19: (ALIM) (AKS) (ORCL) Higher; (CIE) (GIG) (FB) Lower (more...)
Dec 19, 2013 07:02AM Needham & Company Starts GenMark Diagnostics (GNMK) at Buy; Positive on NexGen Analyzer
Jul 12, 2010 10:43AM Notable Analyst Rating Changes 07/12: QCOM, MSFT, YHOO, SNDK Upgraded; ACXM, GLW, MAR, MOLX Downgraded